IP Library Granted Patent US 12,139,741
Granted Patent B2
US 12,139,741 · App. 16/664,264 · Granted Nov 12, 2024

Biocide compositions compatible with enzyme biosensors and methods of use thereof

Inventors: Dennis Robert Conlon (Shirley, MA); Prasad Pamidi (Burlington, MA)
Assignee: Instrumentation Laboratory Company
C12Q1/18C12Q1/34G01N33/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,139,741
App. No.
16/664,264
Granted
Nov 12, 2024
Kind
B2
Abstract

The present disclosure relates to biocide compositions compatible with enzyme biosensors and methods for using same. More particularly, the disclosure relates to biocide compositions compatible with enzymes used for measuring creatine and creatinine levels.

Claims (39)

1. A composition comprising:

enzyme compatible biocides, the enzyme compatible biocides comprising (i) Levofloxacin and (ii) Polymyxin, where the Polymyxin comprises Polymyxin B or Polymyxin E (Colistin);

creatininase;

creatinase; and

sarcosine oxidase.

2. A composition comprising:

an enzyme compatible biocide comprising Polymyxin;

creatininase;

creatinase; and

sarcosine oxidase.

3. A system comprising:

a sensor comprising the composition of claim 2 for measuring a concentration of one or more analytes.

4. The system of claim 3 , wherein the sensor comprises an enzyme biosensor.

5. The system of claim 4 , wherein the enzyme biosensor comprises a creatinine sensor, a creatine sensor, or a combination thereof.

6. The system of claim 3 , further comprising an enzyme compatible biocide having a molecular weight greater than about 320 g/mol.

7. The system of claim 3 , wherein the Polymyxin comprises Polymyxin B, Polymyxin E, or a combination thereof.

8. The system of claim 3 , wherein the Polymyxin comprises Polymyxin B.

9. The system of claim 3 , wherein the composition comprises a fluoroquinolone antibiotic.

10. The system of claim 3 , further comprising a Beta-lactam antibiotic, the Beta-lactam antibiotic comprising amoxycillin, ampicillin, carbenicillin, cefazolin, cefepime, cefoxitin, ceftazidime, clavulanic acid, imipenem, oxacillin, penicillin, or piperacillin.

11. The system of claim 3 , further comprising at least one fluoroquinolone antibiotic.

12. The composition of claim 2 , further comprising at least one of Levofloxacin, Carbenicillin disodium, Spectinomycin, Piperacillin, Ceftazidime, Streptomycin, Sulfanilamide, Sulfathiazole sodium, Sulfadimethoxine, or polyhexamethylene biguanide hydrochloride.

13. The composition of claim 2 , wherein the Polymyxin comprises Polymyxin B and Polymyxin E.

14. The composition of claim 2 , further comprising penicillin comprising amoxycillin or benzyl penicillin.

15. The composition of claim 14 , where the penicillin is at a concentration of about 12.5 to about 500 μg/ml.

16. The composition of claim 2 , further comprising carbenicillin at a concentration of about 5 to about 800 μg/mL or an aminoglycoside at a concentration of about 20 to about 800 μg/mL.

17. The composition of claim 2 , further comprising about 15 to about 500 mg/L spectinomycin.

18. The composition of claim 2 , further comprising about 10 to about 500 mg/L of ceftazidime.

19. The composition of claim 2 , further comprising about 10-500 mg/L streptomycin.

20. The composition of claim 2 , wherein the Polymyxin is Polymyxin B.

21. The composition of claim 2 , wherein the Polymyxin is Polymyxin E.

22. The composition of claim 2 , further comprising polyhexamethylene biguanide hydrochloride in a w/v of 0.1 to 0.5% in aqueous solution.

23. The composition of claim 2 , further comprising a fluoroquinolone antibiotic.

24. The composition of claim 2 , wherein the Polymyxin comprises Polymyxin E or Polymyxin B at a concentration of about 20 to 100 mg/L.

25. The composition of claim 2 , wherein the Polymyxin is at a concentration of about 20 to 100 mg/L.

26. A method comprising:

measuring a concentration of one or more analytes using a sensor comprising the composition of claim 2 .

27. The method of claim 26 , wherein the sensor is part of a system, the system comprising a cartridge for an analyzer system.

28. The method of claim 26 , wherein the sensor comprises an enzyme biosensor.

29. The method of claim 28 , wherein the enzyme biosensor comprises a creatinine sensor, a creatine sensor, or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2020
From: CONLON, DENNIS ROBERT; PAMIDI, PRASAD
To: INSTRUMENTATION LABORATORY COMPANY
Reel/Frame 051663/0220 →
Continuity (1)
Related Publication 20210123084A1 · Apr 29, 2021